Ulrike Hostalek
Overview
Explore the profile of Ulrike Hostalek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinon A, Allignol A, Hohenberger T, Foch C, Boutmy E, Hostalek U
J Comp Eff Res
. 2024 Oct;
13(11):e230027.
PMID: 39417364
Dependent censoring involves a preferential attrition of a subgroup of interest; occurring in survival analysis, it may impact interpretation by introducing a selection bias. To assess the potential bias in...
2.
Foch C, Allignol A, Hostalek U, Boutmy E, Hohenberger T
Int J Clin Pract
. 2022 Aug;
2022:6124559.
PMID: 35989866
Aim: The aim of the study was to compare the effectiveness of beta-blockers with other antihypertensive classes in reducing all-cause mortality, cardiovascular-related mortality and the risk of cerebrocardiovascular events. Methods:...
3.
Foch C, Allignol A, Hohenberger T, Boutmy E, Schaefer S, Hostalek U
J Comp Eff Res
. 2022 Feb;
11(6):423-436.
PMID: 35189710
To compare blood pressure (BP) and safety outcomes in patients with hypertension initiating bisoprolol, versus other β-blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, calcium channel blockers or diuretics. New user...
4.
Hostalek U, Campbell I
Curr Med Res Opin
. 2021 Jul;
37(10):1705-1717.
PMID: 34281467
We have conducted a narrative review based on a structured search strategy, focusing on the effects of metformin on the progression of non-diabetic hyperglycemia to clinical type 2 diabetes mellitus....
5.
Hostalek U, Zilahi Z
Curr Med Res Opin
. 2019 Dec;
36(3):397-401.
PMID: 31793818
Prediabetes is characterized by elevation of indices of blood glucose that is insufficient to provoke a diagnosis of type 2 diabetes, but markedly increases the risk of developing type 2...
6.
Gebregergish S, Hashim M, Heeg B, Wilke T, Rauland M, Hostalek U
Expert Rev Pharmacoecon Outcomes Res
. 2019 Nov;
20(2):207-219.
PMID: 31674846
: Our aim was to systematically identify and appraise cost-effectiveness studies of metformin in prediabetic subjects.: A systematic literature review was conducted and reported according to standard guidlines. The search...
7.
Hostalek U
Clin Diabetes Endocrinol
. 2019 May;
5:5.
PMID: 31086677
Prediabetes is defined as an intermediate state of hyperglycaemia with glucose levels above the normal state but below the diagnostic levels of diabetes. It is increasingly recognised as an important...
8.
Razvi S, Hostalek U
Curr Med Res Opin
. 2019 Jan;
35(7):1215-1220.
PMID: 30648440
Normalizing serum thyroid stimulating hormone (TSH) levels by lifelong treatment with levothyroxine (LT4) remains the primary goal of therapy for patients with hypothyroidism. The reference ranges for TSH are derived...
9.
Khalil S, Abdelaziz S, Al Shammary A, Al Zahrani A, Amir A, Elkafrawy N, et al.
Diab Vasc Dis Res
. 2019 Jan;
16(3):213-226.
PMID: 30606039
Most data on the burden of diabetes and prediabetes are from countries where local infrastructure can support reliable estimates of the burden of non-communicable diseases. Countries in the Middle East...
10.
Lipp H, Hostalek U
Curr Med Res Opin
. 2018 Nov;
35(1):147-150.
PMID: 30406687
Small variations in the dose of levothyroxine have been associated with marked variations in thyroid function in people with hypothyroidism. Accordingly, regulators have identified levothyroxine as a "narrow therapeutic index"...